Pular para o conteúdo principal
Ranking Invest

ANGO - AngioDynamics, Inc.

Segmento: HealthcareAngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Análise Ranking Invest

Valor de Mercado
$ 634.87 Mi
IVR
-0.17Índice proprietário de comparação relativa: -0,17.
IVR2
-0.43Leitura proprietária complementar: -43%.
MLL
-0.43Leitura proprietária complementar: -43%.
Último Balanço Atualizado: 1T2027

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 163.96 Mi

Dívida Líquida

-$ 33.97 Mi

L4T

-$ 32.94 Mi

MM4T

-10.06%

Indicadores Básicos

ROE

-20.09%

Índices de Previsibilidade

Receita Líquida

C0.06

Lucro

E1.22

Margem

E1.25

Índices de Tendência

Receita Líquida

D-1.57

Lucro

D-0.84

Margem

D-0.97

Índices de Endividamento

DIV/PAT

-0.21

DIV/L4T

1.03

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.